Lv4
620 积分 2021-05-16 加入
Combination of paclitaxel and carboplatin as second‐line therapy for patients with metastatic melanoma
1个月前
已完结
Overall survival and subsequent therapy from a phase II study of sintilimab and anlotinib in patients with advanced or recurrent endometrial cancer
1个月前
已完结
Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck
1个月前
已完结
Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study
1个月前
已完结
EP148/#437 Combination of niraparib and anlotinib in patients with recurrent or metastatic endometrial cancer: an open-label, single-arm, two-stage, phase II study
1个月前
已关闭
Preliminary results of trial NPC‐0501 evaluating the therapeutic gain by changing from concurrent‐adjuvant to induction‐concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma
1个月前
已完结
Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer
1个月前
已完结
Perioperation ulinastatin intervention protects liver function in hepatectomy: a systematic review of randomized controlled trials and meta-analysis
1个月前
已完结
A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002)
1个月前
已完结
Recombinant human endostatin plus paclitaxel/nedaplatin for recurrent or metastatic advanced esophageal squamous cell carcinoma: a prospective, single-arm, open-label, phase II study
1个月前
已完结
皖公网安备34019202002308
